Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature
- PMID: 30593169
- PMCID: PMC6314763
- DOI: 10.1097/MD.0000000000013806
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: Case series and a review of the literature
Abstract
Rationale: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare idiopathic disease with only about 100 cases reported in the literature.
Patient concerns: Here, we presented 4 cases of DIPNECH. Four patients included 2 females and 2 males, aged 54 to 64 years old; 3 had no smoking history and 1 had history of smoking for 30 years. Surgical resection was performed for every patient. Cases 1 and 3 did not receive postoperative chemotherapy or radiotherapy, and case 2 received 4 times of postoperative chemotherapy. Case 4 just finished the operation and after a period of time, he will receive postoperative chemotherapy.
Diagnoses: Case 1: A 57-year-old female had chest pain, and computer tomography (CT) examination prompted a mass shadow of left lung lower lobe. Case 2: A 64-year-old female had cough and expectoration for more than 1 month. CT examination showed: a lump with diameter of about 2.5 cm and irregular edge was in right lung upper lobe, being largely possibly lung cancer. Case 3: A 54-year-old male, CT examination accidentally found a long strip-shaped nodule in left lung oblique fissure when checkup's, and he had no fever, cough, expectoration, chest tightness, or chest pain. Case 4: A 61-year-old male, checkup's CT examination accidentally found a nodule, fibrosis, bronchiectasis, and secondary infection in the left lower lobe. Combined with pathological morphology and immunohistochemistry, cases 1 and 3 were diagnosed as DIPNECH with multiple carcinoid tumorlet formation and chronic inflammation and bronchiectasis, case 2 was diagnosed as an adenocarcinoma with DIPNECH and multiple carcinoid tumorlet formation, case 4 was diagnosed as an adenocarcinoma with DIPNECH and multiple carcinoid tumorlet formation and chronic inflammation and bronchiectasis.
Interventions: Surgical resection was performed for every patient. Cases 1 and 3 did not receive postoperative chemotherapy or radiotherapy, and case 2 received 4 times of postoperative chemotherapy. Case 4 just finished the operation and after a period of time, he will receive postoperative chemotherapy.
Outcomes: Four patients have been followed up and have had good condition.
Lessons: DIPNECH is often found accidentally in a surgical specimen, is easily missed, and needs careful observation. Immunohistochemistry is necessary to make this diagnosis.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Walker CM, Vummidi D, Benditt JO, et al. What is DIPNECH? Clin Imaging 2012;36:647–9. - PubMed
-
- Marchevsky AM, Walts AE. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Semin Diagn Pathol 2015;32:438–44. - PubMed
-
- Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of Lung, Pleura, Thymus and Heart. 2015;Lyon: IARC, 63–85. - PubMed
-
- Wirtschafter E, Walts AE, Liu ST, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia of the lung (DIPNECH); current best evidence. Lung 2015;193:659–67. - PubMed
-
- Stella S, Bruzzese A. Digestive neoplasms of the diffuse neuroendocrine system: physiopathologic and clinical aspects. G Chir 1998;19:5–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
